Medical Policy and Coding Updates - July 2019
Summary
Effective July 1, 2019, HER2 inhibitor codes J9356, Q5112, Q5113 and Q5114 and rituximab biosimilar code Q5115 now require review for medical necessity and prior authorization, and transcatheter mitral valve repair code 0544T now requires review for medical necessity and prior authorization. Corneal collagen cross-linking codes 0402T and J2787 and filgrastim biosimilar code Q5110 no longer require review for medical necessity, and J2787 and Q5110 no longer require prior authorization. Codes 0087U, 0088U, 0089U, 0090U, 0094U, 0101U, 0102U, 0103U and 0104U are now reviewed by AIM Specialty Health.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.